SCHEMBL23201243

SCHEMBL23201243

COc1ccc(C(=O)c2cccc(-c3ccc(OC)c(OC)c3)c2)cc1OC

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.71
CYP3A4 P08684 2/20 0.71
CYP2C19 P33261 2/20 0.71
CYP2C9 P11712 1/20 0.71
TSHR P16473 1/20 0.71
ALDH1A1 P00352 5/20 0.61
GAA P10253 3/20 0.61
POLB P06746 1/20 0.54
PDE4A P27815 1/20 0.54
PDE4B Q07343 1/20 0.54
PDE4C Q08493 1/20 0.54
PDE4D Q08499 1/20 0.54
CA12 O43570 1/20 0.54
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
CA4 P22748 1/20 0.54
CA6 P23280 1/20 0.54
CA7 P43166 1/20 0.54
TPMT P51580 1/20 0.54
CA9 Q16790 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30514361 1.00 CYP1A2 (0.71) CYP1A2CYP3A4CYP2C19CYP2C9TSHR
SCHEMBL27976009 0.85 CYP1A2 (0.62) CYP1A2CYP3A4CYP2C19CYP2C9TSHR
SCHEMBL1010387 0.85 CYP1A2 (0.73) CYP1A2CYP3A4CYP2C19CYP2C9TSHR
SCHEMBL5151529 0.85 PDE4A (0.71) CYP1A2CYP3A4TSHRGAAPOLB
SCHEMBL10316407 0.85 FYN (0.60) CYP1A2CYP3A4CYP2C19CYP2C9TSHR
SCHEMBL1493250 0.84 CYP1A2 (1.00) CYP1A2CYP3A4CYP2C19CYP2C9TSHR
SCHEMBL10316380 0.84 CYP1A2 (0.54) CYP1A2CYP3A4CYP2C19CYP2C9TSHR
SCHEMBL12560338 0.84 ERN1 (0.63) CYP1A2CYP3A4POLBPDE4APDE4B
SCHEMBL1333620 0.83 CYP1A2 (0.81) CYP1A2CYP3A4CYP2C19CYP2C9TSHR
SCHEMBL430038 0.83 TUBB4A (0.59) CYP1A2CYP3A4CYP2C19CYP2C9TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12043594-B2 Biphenyl derivative compound and use thereof EWHA University—Industry Collaboration Foundation (KR) 2024-07-23 US disclosed
US-20210206706-A1 Novel Biphenyl Derivative Compound and Use Thereof EWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATION (KR) 2021-07-08 US disclosed
US-20210206706-A1 Novel Biphenyl Derivative Compound and Use Thereof EWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATION (KR) 2021-07-08 US disclosed
EP-3805193-A1 NOVEL BIPHENYL DERIVATIVE COMPOUND AND USE THEREOF Ewha University-Industry Collaboration Foundation (KR) 2021-04-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12043594-B2 Biphenyl derivative compound and use thereof NME4, PCK2, DNAJA3 CYP1A2 3588/4885CYP3A4 2994/4885CYP2C19 1891/4885
US-20210206706-A1 Novel Biphenyl Derivative Compound and Use Thereof NME4, PCK2, DNAJA3 CYP1A2 3571/4885CYP3A4 3056/4885CYP2C19 2065/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.